Market Overview

Second Sight to Present at the 28th Annual ROTH Conference on March 14, 2016


Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today announced that Will McGuire, President and Chief Executive Officer, will present at the 28th Annual ROTH Conference as follows:

Date:     Monday, March 14, 2016
Time: 2:00 p.m. PST (5:00 p.m. EST)
Location: The Ritz-Carlton, Laguna Niguel, Salon 2 - BLUE

The Company will also host one-on-one meetings throughout the day.

The presentation will be webcast live at the aforementioned time as well as archived for 90 days thereafter at, or via the Company's website at, under the Investors Section.

About Second Sight

Second Sight's mission is to develop, manufacture and market innovative implantable visual prosthetics to enable blind individuals to achieve greater independence. Second Sight has developed and manufactures the Argus® II Retinal Prosthesis System. Enrollment is underway in a trial to test the safety and utility of the Argus II in individuals with Dry Age-Related Macular Degeneration. Second Sight is also developing the Orion™ I Visual Cortical Prosthesis to restore some vision to individuals who are blind due to causes other than preventable or treatable conditions. U.S. Headquarters are in Sylmar, CA, and European Headquarters are in Lausanne, Switzerland. For more information, visit

Second Sight
Institutional Investors
In-Site Communications, Inc.
Lisa Wilson, 212-452-2793
Individual Investors
MZ North America
Greg Falesnik, 949-385-6449
Senior Vice President

View Comments and Join the Discussion!